Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.072 HKD | -4.00% | +28.57% | -15.29% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 188.6 | 156.5 | 89.58 | 100.6 | 107.7 | 107.5 |
Enterprise Value (EV) 1 | 60.46 | 17.89 | -32.45 | -16.19 | -16.18 | -45.5 |
P/E ratio | -9.76 x | -18.7 x | -23.5 x | -33.8 x | -10.9 x | -127 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 3.11 x | 2.5 x | 1.34 x | 1.47 x | 1.48 x | 1.38 x |
EV / Revenue | 1 x | 0.29 x | -0.49 x | -0.24 x | -0.22 x | -0.58 x |
EV / EBITDA | -4.21 x | -6.92 x | 16 x | -2.19 x | 1.72 x | -4.55 x |
EV / FCF | 3.33 x | 1.4 x | -8.45 x | -2.05 x | -0.8 x | -10.4 x |
FCF Yield | 30% | 71.6% | -11.8% | -48.8% | -125% | -9.61% |
Price to Book | 1.65 x | 1.49 x | 0.71 x | 0.84 x | 0.94 x | 0.95 x |
Nbr of stocks (in thousands) | 742,500 | 742,500 | 742,500 | 742,500 | 742,500 | 742,500 |
Reference price 2 | 0.2540 | 0.2107 | 0.1206 | 0.1355 | 0.1450 | 0.1448 |
Announcement Date | 3/28/18 | 3/29/19 | 7/1/20 | 4/30/21 | 4/26/22 | 3/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 60.71 | 62.67 | 66.61 | 68.34 | 72.86 | 77.97 |
EBITDA 1 | -14.35 | -2.584 | -2.029 | 7.399 | -9.429 | 10.01 |
EBIT 1 | -19.26 | -4.882 | -4.04 | 2.047 | -12.14 | 7.792 |
Operating Margin | -31.72% | -7.79% | -6.07% | 3% | -16.66% | 9.99% |
Earnings before Tax (EBT) 1 | -19.28 | -7.415 | -2.928 | 1.479 | -14.77 | 7.888 |
Net income 1 | -19.33 | -8.352 | -3.804 | -2.974 | -9.872 | -0.847 |
Net margin | -31.85% | -13.33% | -5.71% | -4.35% | -13.55% | -1.09% |
EPS 2 | -0.0260 | -0.0112 | -0.005123 | -0.004005 | -0.0133 | -0.001140 |
Free Cash Flow 1 | 18.14 | 12.81 | 3.839 | 7.894 | 20.2 | 4.371 |
FCF margin | 29.88% | 20.45% | 5.76% | 11.55% | 27.72% | 5.61% |
FCF Conversion (EBITDA) | - | - | - | 106.69% | - | 43.68% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/28/18 | 3/29/19 | 7/1/20 | 4/30/21 | 4/26/22 | 3/31/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 128 | 139 | 122 | 117 | 124 | 153 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 18.1 | 12.8 | 3.84 | 7.89 | 20.2 | 4.37 |
ROE (net income / shareholders' equity) | -17% | -7.93% | -3.78% | -1.69% | -16.3% | 0.53% |
ROA (Net income/ Total Assets) | -4.96% | -1.3% | -0.95% | 0.45% | -2.8% | 1.78% |
Assets 1 | 389.4 | 641.8 | 399 | -663.5 | 352.4 | -47.71 |
Book Value Per Share 2 | 0.1500 | 0.1400 | 0.1700 | 0.1600 | 0.1500 | 0.1500 |
Cash Flow per Share 2 | 0.1300 | 0.1400 | 0.1600 | 0.1700 | 0.1600 | 0.1500 |
Capex 1 | 1.33 | 1.55 | 0.75 | 3.71 | 1.3 | 2.47 |
Capex / Sales | 2.18% | 2.47% | 1.13% | 5.43% | 1.79% | 3.17% |
Announcement Date | 3/28/18 | 3/29/19 | 7/1/20 | 4/30/21 | 4/26/22 | 3/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.29% | 8.14M | |
-0.94% | 1.52B | |
+5.97% | 549M | |
+3.10% | 478M | |
-15.30% | 415M | |
-0.36% | 378M | |
-2.34% | 141M | |
+11.69% | 67.24M | |
-2.88% | 66.7M | |
-1.75% | 64.35M |
- Stock Market
- Equities
- 8296 Stock
- Financials Sino-Life Group Limited